Market Tracker

10/24 6:05pm ET

Novavax Inc (NASDAQ:NVAX)

5.13
Data as of Oct 24
 +0.14 / +2.81%
Today’s Change
2.68
Today|||52-Week Range
6.95
+0.20%
Year-to-Date

Today’s Trading

Previous close4.99
Today’s open5.02
Day’s range4.99 - 5.25
Volume5,755,857
Average volume (3 months)3,319,405
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+5.03%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book5.27

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+1.67+4.25%
KITEKite Pharma Inc-0.60-1.77%
HALOHalozyme Therapeutic...-0.11-1.19%
OPHTOphthotech Corp-0.12-0.30%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts